Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

Clinical trial NCT05668390 · COMPLETED

Trial details

NCT number: NCT05668390
Sponsor: Stallergenes Greer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis Birch Pollen Allergy

Start date: 2023-09-20
Primary completion: 2025-08-06
Enrollment: 553

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.